Tumor cell uptake machinery

Tumor cell uptake machinery refers to the collective set of biological processes and proteins that malignant cells utilize to internalize extracellular materials, including nutrients, signaling molecules, and therapeutic agents (Sahay et al., 2010, Nature Nanotechnology). This machinery encompasses various endocytic pathways—such as clathrin-mediated endocytosis, caveolae-mediated endocytosis, and macropinocytosis—as well as specialized transmembrane transporters like GLUT1 and LAT1 (Doherty and McMahon, 2009, Annual Review of Biochemistry). Cancer cells frequently upregulate these components to sustain rapid proliferation and meet increased metabolic demands, a phenomenon often linked to oncogenic signaling (Mellman and Yarden, 2013, Cold Spring Harbor Perspectives in Biology). In oncology, this machinery is exploited for the delivery of targeted therapies, such as antibody-drug conjugates (ADCs) and nanoparticle-based systems, which rely on these internalization routes to reach their intracellular targets (Chau et al., 2013, Science Translational Medicine). Despite its utility for drug delivery, the complexity and redundancy of these uptake routes, along with their presence in normal tissues, pose significant challenges for achieving high therapeutic indices and overcoming drug resistance (Kou et al., 2013, African Journal of Pharmacy and Pharmacology).

Other names

Endocytic machineryCellular internalization pathwaysNutrient uptake systemsCancer cell internalization apparatus

Exploitation of receptor-mediated endocytosis or transporter-mediated influx for the intracellular delivery of cytotoxic payloads, nucleic acids, or imaging agents.